Atlas Trials

Low-Dose Ibuprofen in Improving Cognitive Impairment in Patients With Cancer

Clinical trial NCT03186638 · COMPLETED

Trial details

NCT number
NCT03186638
Sponsor
University of Rochester NCORP Research Base
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cognitive ImpairmentMalignant Neoplasm
Start date
2017-05-26
Primary completion
2022-03-30
Enrollment
87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.